Biosion, Inc.
Clinical trials sponsored by Biosion, Inc., explained in plain language.
-
New shot shows promise for tough eczema in early trial
Disease control CompletedThis study tested a new medicine called BSI-045B in 22 adults with moderate to severe atopic dermatitis (eczema). Participants received injections weekly for 4 weeks, then every 2 weeks for 20 more weeks. The main goal was to see if the treatment could reduce eczema severity by a…
Phase: PHASE2 • Sponsor: Biosion, Inc. • Aim: Disease control
Last updated May 26, 2026 11:14 UTC
-
New eczema drug shows promise in early human tests
Symptom relief CompletedThis early-stage study tested a new medicine called BSI-045B in 54 healthy volunteers and people with eczema (atopic dermatitis). The main goal was to check if the drug is safe and tolerable. Researchers gave different doses as injections under the skin and monitored side effects…
Phase: PHASE1 • Sponsor: Biosion, Inc. • Aim: Symptom relief
Last updated May 20, 2026 12:02 UTC